Related Experiment Video
Updated: May 27, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity
A Giralt1, M Puigdellívol, O Carretón
1Departament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.
Insights
Huntington's disease (HD) causes early memory deficits in mice due to reduced CREB-binding protein (CBP). Histone deacetylase inhibitors restored memory function, suggesting a new therapeutic approach for HD cognitive impairment.
Area of Science:
- Neurodegenerative Diseases
- Genetics
- Epigenetics
- Cognitive Neuroscience
Background:
- Huntington's disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion in the huntingtin gene.
- While known for motor symptoms, early cognitive deficits precede motor disturbances in HD patients.
Purpose of the Study:
- To investigate early cognitive impairments in a mouse model of Huntington's disease.
- To explore the molecular mechanisms underlying cognitive deficits in HD, focusing on CREB-binding protein (CBP) and histone acetylation.
- To evaluate the therapeutic potential of histone deacetylase inhibitors for HD-related memory dysfunction.
Main Methods:
- Utilized heterozygous HD knock-in mutant mice (Hdh(Q7/Q111)) as an accurate model for HD.
- Assessed long-term spatial and recognition memory in Hdh(Q7/Q111) mice.
- Measured hippocampal expression of CBP, histone H3 acetylation, and CREB/CBP target genes (e.g., c-fos, Arc, Nr4a2).
- Administered the histone deacetylase inhibitor trichostatin A to Hdh(Q7/Q111) mice and evaluated its effect on memory and gene transcription.
Main Results:
- Hdh(Q7/Q111) mice exhibited impaired long-term spatial and recognition memory.
- Cognitive deficits correlated with reduced hippocampal CBP expression and histone H3 acetylation.
- Expression of key CREB/CBP target genes involved in memory was significantly decreased in Hdh(Q7/Q111) mice.
- Treatment with trichostatin A rescued recognition memory deficits and normalized transcription of selective CREB/CBP target genes.
Conclusions:
- CREB-binding protein (CBP) plays a critical role in the cognitive dysfunction observed in Huntington's disease.
- Reduced CBP levels and histone acetylation contribute to memory deficits in HD.
- Histone deacetylase inhibitors represent a promising therapeutic strategy for treating memory impairments in Huntington's disease.
Abstract:
Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder caused by an expanded CAG/polyglutamine repeat in the coding region of the huntingtin (htt) gene. Although HD is classically considered a motor disorder, there is now considerable evidence that early cognitive deficits appear in patients before the onset of motor disturbances. Here we demonstrate early impairment of long-term spatial and recognition memory in heterozygous HD knock-in mutant mice (Hdh(Q7/Q111)), a genetically accurate HD mouse model. Cognitive deficits are associated with reduced hippocampal expression of CREB-binding protein (CBP) and diminished levels of histone H3 acetylation. In agreement with reduced CBP, the expression of CREB/CBP target genes related to memory, such c-fos, Arc and Nr4a2, was significantly reduced in the hippocampus of Hdh(Q7/Q111) mice compared with wild-type mice. Finally, and consistent with a role of CBP in cognitive impairment in Hdh(Q7/Q111) mice, administration of the histone deacetylase inhibitor trichostatin A rescues recognition memory deficits and transcription of selective CREB/CBP target genes in Hdh(Q7/Q111) mice. These findings demonstrate an important role for CBP in cognitive dysfunction in HD and suggest the use of histone deacetylase inhibitors as a novel therapeutic strategy for the treatment of memory deficits in this disease.
More Related Videos
Related Concept Videos
Huntington Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Hippocampus in Memory

